By using the relevant TH-MYCN pre-clinical NB model, we evaluated in vivo the hypoxic status and growth of TH-MYCN tumors treated with JQ1 alone or in combination with anti-PD-1. This evidence concerns the gene PDCD1 and neuroblastoma.